For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of Tafamidis and Attruby represents a genuine change. These innovative therapies protect the transthyretin protein, halting its harmful build-up and alleviating the impact of the condition . Patients are now reporting benefits in their w… Read More